ez io

Card Set Information

ez io
2014-10-02 18:17:38
ezio mad
ez io study cards
Show Answers:

  1. PURPOSE Intraosseous cannulation provides a safe and reliable method for rapidly achieving a route for administration of medications, fluids, and blood products in a non-collapsible vascular space
    indications.One failed attempt at intravenous access or after evaluation of potential IV sites, it is determined that an IV attempt would not be successful and patient meets one of the following criteria; 1.One of the following conditions exists: 1. Cardiac or respiratory arrest, impending arrest, or unstable dysrythmia 2. Shock or evolving shock, regardless of cause
  2. BSOLUTE CONTRAINDICATIONS A. Fracture or suspected vascular compromise of the selected tibia. B. Congenital deformity or history of osteogenesis imperfecta or osteoporosis C. Previous IO attempt at the chosen site D. Inability to locate anatomical landmarks for insertion. E. Patient <3kg
    RELATIVE CONTRAINDICATIONS A. Skin infection or burn overlying the area of insertion.
  3. EQUIPMENT A. Povidone-based solution B. IV of NS attached to 250 mL bag in pediatric patients C. IV of NS attached to 1000 mL bag in adult patients D. 10/12 mL syringe filled with normal saline E. Sterile gloves F. Adhesive tape G. EZ Stabilizer
    • . Pressure bag for IV fluid administration I. Intraosseous needle (suitable up to age 8)
    • J. Automated IO insertion device (EZ-IOPD) up to 40 kg K. Automated IO insertion device (EZ-IOAD) if over 40 kg L. Lidocaine 2% for injection
  4. PROCEDURE A. Locate and prepare the insertion site. For children, place supine with a rolled towel under the knee, restrain if necessary. Select extremity (if applicable) without evidence of trauma or infection. B. Put on gloves and thoroughly prepare the area with the antiseptic solution.
    Locate insertion site: i. In small children (3-12 kg), the tibial tuberosity cannot be palpated as a landmark, so the insertion site is two finger-breadths below the patella in the flat aspect of the medial tibia.
  5. In larger children (13-39 kg), the insertion site is located on the flat aspect of the medial tibia one finger breadth below the level of the tibial tuberosity. If tibial tuberosity not palpable, insert two finger-breadths below the patella in the flat aspect of the medial tibia.
    For adults, proximal or distal tibial sites may be utilized. 1. The proximal tibial site is one finger-breadth medial to the tibial tuberosity. 2. The distal tibial site is 2 finger-breadths above the medial malleolus (inside aspect of ankle) in the midline of the shaft of the tibia
  6. D. Stabilize extremity. E. Introduce the intraosseous needle at a 90 degree angle, to the flat surface of the tibia. F. For manual insertion, pierce the bony cortex using a firm rotary or drilling motion (do not move needle side to side or up and down). A distinct change in resistance will be felt upon entry into the medullary space. G. Remove the stylet and confirm intramedullary placement by injecting, without marked resistance, 10 mL normal saline.
    K. Monitor pulses distal to area of placement L. Monitor leg for signs of swelling or cool temperature which may indicate infiltration of fluids into surrounding tissues. M. For adult patients who awaken and have pain related to infusion, slowly administer SO - LIDOCAINE 40 mg IO. May repeat dose once at 20 mg LIDOCAINE IO. N. For pediatric patients with pain related to infusion, slowly administer SO - LIDOCAINE 0.5 mg/kg IO (max dose 20 mg).
  7. POSSIBLE COMPLICATIONS A. Local infiltration of fluids/drugs into the subcutaneous tissue due to improper needle placement. B. Cessation of the infusion due to clotting in the needle, or the bevel of the needle being lodged against the posterior cortex. C. Osteomyelitis or sepsis D. Fluid overload E. Fat or bone emboli F. Fracture
  8. PURPOSE: To define the indications and use of intranasal medication administration in the prehospital setting by Paramedics and AEMT personne
    Poisoning – Narcotic Overdose 1) Indicated for patients who are unconscious/unresponsive in whom an opiate overdose is suspected without IV access who require urgent medication administration
  9. Altered neurologic function - Seizures 1) Indicated for patients who are actively seizing without IV access who require urgent medication administration
    Behavioral emergencies – For patients exhibiting severe agitation 1) Indicated for severely agitated patients who require urgent medication administration to reduce the risk of injury to patient or others
  10. III) CONTRAINDICATIONS: A) Epistaxis B) Nasal trauma C) Nasal septal abnormalities D) Nasal congestion or discharge
    III) APPROVED MEDICATIONS FOR INTRANASAL ROUTE: A) Glucagon B) Naloxone (Narcan) C) Midazolam (Versed) – 5 mg/ml concentration required
  11. A) Determine appropriate medication dose per protocol B) Draw up medication into a syringe using appropriate transfer needle C) Purge air from syringe D) Place mucosal atomization device on the end of the syringe and screw into place E) Gently insert the atomizer into the nare. Stop once resistance is met F) Rapidly as administer the medication when patient fully exhales and before inhalation.
    • ADMINISTER ½ DOSE IN EACH NOSTRILG) Do not exceed 1.0 ml per nostril
    • H) Monitor ECG, Vital Signs (BP, HR, RR, SPO₂) I) Evaluate the effectiveness of the medication, if the desired effect has not been achieved, consider repeating and/or changing route of administration
  12. PRECAUTIONS: A) Nasal administration does not always work for every patient B) Nasal administration is less likely to be effective if the patient has been abusing inhaled vasoconstrictors such as cocaine